I Flow Usage: Impact of Postarthroscopic Glenohumeral Chondrolysis on the pain pump market
A Survey of 118 Surgeons and Anesthesiologists
Deliverable: Survey with key findings.
Study Description:
|
Topic |
Impact of Postarthroscopic Glenohumeral Chondrolysis on the Pain Pump Market |
|
Respondent Type |
Physicians |
|
Specialties Covered |
General, Orthopedic, OBGYN, Urology, Cardiothoracic, and Plastic Surgeons, Anesthesiologists |
|
Region |
United States Only |
|
Methodology |
Online survey, self-administered via a Panel Intelligence website Duration: 20 minutes Size: 118 respondents Fielding Dates: November 22, 2007 to November 24, 2007 |
Objectives:
To assess the pain pump market in the context of a negative research article published in the American Journal of Sports Medicine. Additional objectives include:
§ Determine past, current, and future use of I-Flow as well as competing products.
· Barriers to increase usage of I-Flow.
§ Ratings of products and attributes across brands.
§ Awareness of the Hansen study.
§ Presentation of a study and determine level of concern.
§ Re-prediction of future use.
Companies and Products Mentioned in This Report:
|
Company |
Ticker Symbol |
Product(s) |
|
I-Flow Corporation |
IFLO |
ON-Q PainBuster Post-Op Pain Relief System |
|
Medtronic |
MDT |
Pain-Control Pump |
|
Sorenson Medical |
Privately Held |
ambIT Pain Pump |
|
Stryker Corporation |
SYK |
PainPump |
|
Zimmer Holdings, Inc. |
ZMH |
Ambulatory Pump |
Inclusion Criteria and Respondent Demographics:
|
Inclusion Criteria
|
§ Board-certified or eligible § In practice between 2 and 30 years § Have used a pain pump in the past six months |
| © Panel Intelligence, LLC. 1999-2008. All rights reserved. A wholly owned subsidiary of MCF Corporation (NASDAQ: MERR) Privacy Policy |